Literature DB >> 1498720

Hypertensive structural changes in blood vessels: do endothelial cells hold the key?

M E Todd1.   

Abstract

In recent decades, the complexity of the endothelium and its major role in maintaining or altering blood vessel architecture are being revealed. In contrast, the vascular smooth muscle cell previously received the most attention. I suggest support of the hypothesis that the endothelium is the key to vascular disease. An altered endothelium in diabetes mellitus likewise is likely to be pivotal in vascular complications that develop. We have demonstrated that adherent monocytes, indicators of altered endothelium, occur in deoxycorticosterone acetate induced hypertension in male Wistar rats. The coronary artery and thoracic aorta were investigated using transmission electron microscopy. Details of hypertensive changes were revealed as well as early atherogenic pathology in the absence of dietary modifications. Scanning electron microscopy of thoracic aorta showed details of the luminal endothelial surface and adherent monocyte-macrophages in hypertensive animals. There were two cell types: numerous typical monocytes with upstream tails, and larger cells that may have been free grazing macrophages or macrophages that had returned to the circulation. Debris and amorphous material were particularly evident in vessels from hypertensive animals. Monocytes squeezed between intact endothelial plasma membranes (as seen in section), and were found as subendothelial foam cells and phagocytosing macrophages. The endothelial adherence of monocytes to the aortas from diabetic animals was significantly (p less than 0.05) elevated over that found in controls (but not different from control-hypertensive or diabetic-hypertensive animals) supporting the concept of altered endothelium in diabetes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498720     DOI: 10.1139/y92-069

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats.

Authors:  T Hérembert; D L Zhu; P Marche
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

2.  The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study.

Authors:  Mizue Fujii; Hirofumi Ohnishi; Shigeyuki Saitoh; Hiroshi Akasaka; Tetsuji Miura; Mitsuru Mori
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus.

Authors:  Karine Sahakyan; Barbara E K Klein; Chelsea E Myers; Michael Y Tsai; Ronald Klein
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

4.  Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women.

Authors:  Lu Wang; Joann E Manson; J Michael Gaziano; Simin Liu; Barbara Cochrane; Nancy R Cook; Paul M Ridker; Nader Rifai; Howard D Sesso
Journal:  Clin Chem       Date:  2011-03-11       Impact factor: 8.327

5.  Effects of vitamin E deficiency on vasomotor activity and ultrastructural organisation of rat thoracic aorta.

Authors:  A Rubino; A Loesch; M A Goss-Sampson; P Milla; G Burnstock
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

6.  Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men.

Authors:  Howard D Sesso; Monik C Jiménez; Lu Wang; Paul M Ridker; Julie E Buring; J Michael Gaziano
Journal:  J Am Heart Assoc       Date:  2015-09-21       Impact factor: 5.501

7.  Elevated Lipoprotein-Associated Phospholipase A2 Independently Affects Age-Related Increases in Systolic Blood Pressure: A Nested Case-Control Study in a Prospective Korean Cohort.

Authors:  Hye Jin Yoo; Minjoo Kim; Sang-Hyun Lee; Jong Ho Lee
Journal:  Int J Hypertens       Date:  2020-03-31       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.